Research Article

A Drug Utilization Study To Assess The Usage Of The Fixed-Dose Combination (FDC) Of Teneligliptin + Dapagliflozin In Indian Patients With Type2 Diabetes Mellitus (T2DM) At Various Clinics Across India

A Drug Utilization Study To Assess The Usage Of The Fixed-Dose Combination (FDC) Of Teneligliptin + Dapagliflozin In Indian Patients With Type2 Diabetes Mellitus (T2DM) At Various Clinics Across India

Vijay Neglur, Narasimman VKR, Chavi Agarwal, Shivarama Krishna, Aditya Verma, Sumit Bhushan, Sanjay Choudhari, Rahee Borulkar, Kiransing Pawar, Saiprasad Patil

Current Trends in Internal Medicine

Review Article

Effectiveness and Safety of Triple Combination of Sitagliptin + Pioglitazone + Metformin In T2DM Patients: a Retrospective, Multi-Centre Study

Effectiveness and Safety of Triple Combination of Sitagliptin + Pioglitazone + Metformin In T2DM Patients: a Retrospective, Multi-Centre Study

Alok Agarwal, Mehul Sundesha, Manoj Mali, Sanjay Gupta, Sumit Bhushan, Sanjay Chaudhari, Rahee Borulkar, Prajakta Bhosale, Rujuta Gadkari, Saiprasad Patil

Current Trends in Internal Medicine
Update cookies preferences